Personalized Cell Therapy Market
According to Intent Market Research, the Personalized Cell Therapy Market is expected to grow from USD 9.9 billion in 2024-e at a CAGR of 7.5% to touch USD 15.2 billion by 2030. The Personalized Cell Therapy Market is dominated by key players such as, Gilead Sciences, Inc., Novartis AG, Thermo Fisher Scientific, Mesoblast Limited, and Juno Therapeutics (a Bristol Myers Squibb Company).